Chinese scientists develop cure for diabetes, insulin patient becomes medicine-free in just 3 months

Chinese scientists have achieved a major medical milestone by curing a patient's diabetes using innovative cell therapy, as detailed in the journal Cell Discovery on April 30. Developed by teams from Shanghai Changzheng Hospital, the Centre for Excellence in Molecular Cell Science, and Renji Hospital, this treatment transformed the patient's peripheral blood mononuclear cells into "seed cells," recreating pancreatic islet tissue in a lab environment. This regenerative medicine approach restored the patient's pancreatic function, enabling him to become insulin-free within eleven weeks of a July 2021 transplant. Over the next year, he ceased taking oral diabetes medication, remaining insulin-free for 33 months. This breakthrough offers a significant advancement in diabetes treatment, traditionally managed by insulin injections and constant monitoring. The success of this cell therapy could revolutionize diabetes care, particularly in China, which has the highest number of diabetes patients globally. With 140 million diabetics in China, including 40 million reliant on insulin, this therapy could alleviate a significant healthcare burden. Timothy Kieffer of the University of British Columbia commended the study's potential to improve patient health, reduce medication dependence, and lower healthcare costs, while calling for further studies to confirm its effectiveness.